No Data
No Data
Quanterix Announces Commercialization of P-Tau 217 Test Kit
Exact Sciences, Quanterix Extend Slide After Medicare Rates
Leerink Partners Maintains Quanterix(QTRX.US) With Buy Rating
Leerink Sees Preliminary CLFS Determinations as a Negative for Quanterix
Leerink Partners Sticks to Its Buy Rating for Quanterix (QTRX)
Express News | Watching Quanterix; Traders Circulate Analyst Comments Suggesting The Preliminary CLFS Determinations For New Codes Was Just Published With Worse Than Expected Decisions For Neuro Diagnostics, The Advisory Panel Voted To Crosswalk To $130 For Tests...
No Data
No Data